Abstract
Objective: To describe the limitations and challenges encountered while determining the number of ALS cases in the United States.
Background: Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neuromuscular disorder with no cure. The most recent estimates of ALS cases in the United States (U.S.) from the National ALS Registry (Registry) show over 16,000 cases or 5.2 per 100,000 persons for 2015. Unlike many communicable diseases and conditions, ALS is not reported to state and local health officials who would, in turn, notify federal health agencies. In addition, personally identifiable information (PII) data from private health insurance providers are not available to the Registry for determining ALS cases.
Design/Methods: In the event ALS was a reportable disease and data were available from all insurance providers, the Registry would utilize its validated algorithm for case ascertainment. This is based on International Classification of Diseases codes, visits to neurologists, prescriptions for ALS specific drugs, and death certificates. In addition, the Registry is utilizing capture-recapture methodology in order to estimate the number of missing cases. Capture-recapture allows for the correction of under-ascertainment in epidemiology.
Results: The results are currently unknown since ALS is not notifiable to federal health officials and data from private insurance providers are not available. Though it is anticipated the addition of these cases will increase the national prevalence estimates and counts.
Conclusions: Communicable diseases in the U.S. have an inherent advantage when it comes to case-ascertainment on a national scale. The limitations of determining incidence and prevalence for non-communicable diseases are evident since reporting requirements are not available. Better data sources, data sharing, and novel case ascertainment methods are needed in order to provide an accurate estimate of national epidemiologic trends.
Disclosure: Dr. Mehta has nothing to disclose. Dr. Davis has nothing to disclose. Dr. Raymond MPH has nothing to disclose. Dr. Larson has nothing to disclose. Dr. Horton has nothing to disclose.
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.